A Clinical Trial to Evaluate the Effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in Adults With Eczema-Prone Skin

Running, not enrolling · Not applicable

Conditions studied: Eczema, Atopic Dermatitis, Eczema-Prone Skin

In brief

This is a single-arm, open-label, decentralized (fully remote) clinical trial evaluating the tolerability and self-perceived skin effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in 35 adults aged 18-65 with self-reported eczema-prone skin. Participants will use the body wash once daily in place of their usual cleanser, followed by the Skin Recovery Cream, for 4 consecutive weeks.

Key facts

Study ID

NCT07700745

Run by

Rejuvaskin

People needed

35

Starts

2026-07-06

Expected to finish

2026-08-01

Last updated by the study team

2026-07-14

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult women or men aged 18-65 years.
• Self-reported symptoms of eczema or eczema-prone skin (e.g., dryness, roughness, itching, irritation on the body).
• Visible signs of eczema such as dryness, roughness, or irritation on at least one part of the body at the time of enrollment.
• Willing to use Rejuvaskin Eczema Body Wash once daily as their primary body cleanser for 4 consecutive weeks.
• Willing to use Rejuvaskin Skin Recovery Cream once daily after using the - Rejuvaskin body cleanser for 4 consecutive weeks.
• Willing to maintain their current diet, skincare routine (aside from substitution of body wash and skin cream), and lifestyle habits for the study duration.
• Willing and able to take standardized photographs of an affected body area at Baseline and Week 4 using a personal smartphone.
• Able to read, understand, and complete questionnaires in English.
• Resides in the United States with a valid shipping address.
• Willing to provide informed consent and comply with all study procedures

You may not qualify if…

• Known allergy or sensitivity to any ingredient in the study product.
• Currently pregnant, breastfeeding, or planning to become pregnant during the study period.
• Active, severe skin condition on the body requiring prescription topical or systemic treatment (e.g., active severe atopic dermatitis flare under medical care, active infection at intended application sites).
• Currently using prescription topical corticosteroids, calcineurin inhibitors, or other prescription topical eczema treatments on the body, or initiation of such treatment planned during the study.
• Currently participating in another clinical or skincare research study, or planning to enroll during this study's duration. (

Where it is running

• Citruslabs — Las Vegas, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.